Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2013
11/28/2013US20130316402 Antibodies and immunoconjugates and uses therefor
11/28/2013US20130315949 Molecular Antigen Array
11/28/2013US20130315935 Oligomeric receptor ligand pair member complexes
11/28/2013US20130315933 Antibodies Directed Against HLA-B27 Homodimers and Methods and Uses Thereof in Diagnosis and Therapy
11/28/2013US20130315928 Luteinizing-hormone ligand and ligand-gonadotrophin complex
11/28/2013US20130315927 Pcsk9 antagonists
11/28/2013US20130315923 Anti-gcc antibody molecules and related compositions and methods
11/28/2013US20130315921 Human monoclonal antibodies specific for cd22
11/28/2013US20130315919 Anti-il-22ra antibodies
11/28/2013US20130315918 Anti-vegf antibodies
11/28/2013US20130315917 Anitbodies specific for the protofibril form of beta-amyloid protein
11/28/2013US20130315916 Respiratory syncytial virus vaccine
11/28/2013US20130315915 Methods and compositions for diagnosing and treating diseases
11/28/2013US20130315914 Anti-TLR4 Antibodies and Uses Thereof
11/28/2013US20130315913 Anti-light antibody therapy for inflammatory bowel disease
11/28/2013US20130315911 Bispecific antibodies and methods of using the same
11/28/2013US20130315910 Methods and compositions for inhibiting cd32b expressing cells
11/28/2013US20130315909 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
11/28/2013US20130315906 Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof
11/28/2013US20130315905 B7-H5, A Costimulatory Polypeptide
11/28/2013US20130315902 Antitumor peptide derived from a complementarity determining region of a humanized monoclonal antibody to nap12b transporter
11/28/2013US20130315900 Humanized anti-cd40 antibodies conjugated to therapeutic agents
11/28/2013US20130315896 Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
11/28/2013US20130315893 Humanized anti-il-20 antibody and uses thereof
11/28/2013US20130315820 Use of an antibody directed against a membrane protein
11/27/2013EP2666787A1 Stable IgG4 antibodies
11/27/2013EP2666786A1 Immunotherapy for intracranial hemorrhage
11/27/2013EP2666785A1 Complement component C5a-based vaccine
11/27/2013EP2666784A2 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
11/27/2013EP2666480A2 Uses and compositions for treatment of Crohn's desease
11/27/2013EP2666479A2 Uses and compositions for treatment of juvenile rheumatoid arthritis
11/27/2013EP2666478A2 Uses and compositions for treatment of psoriasis
11/27/2013EP2666472A2 Uses and compositions for treatment of psoriatic arthritis
11/27/2013EP2665822A1 Nav1.7 knockout mice and uses thereof
11/27/2013EP2665751A1 Binding proteins to inhibitors of coagulation factors
11/27/2013EP2665750A1 Il-21 ligands
11/27/2013EP2665749A1 Anti - il1rap antibodies and their use for treating human
11/27/2013EP2665746A1 Antibodies against the s100p protein for the treatment and diagnosis of cancer
11/27/2013EP2665521A2 Compositions and methods for treating cancer
11/27/2013CN103415534A Antigen presenting cell targeted cancer vaccines
11/27/2013CN103415533A Ice crystallization inhibitor derived from plant seeds
11/27/2013CN103415301A Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
11/27/2013CN103409455A Egg yolk antibody anti-human enterotoxigenic escherichia coli adhesion protein and application thereof
11/27/2013CN103408667A Cystatin C nano antibody and coding sequence thereof
11/27/2013CN103408666A Humanized anti-AEG-1 single chain antibody and application thereof
11/27/2013CN103408665A N-substituted tetrahydropyridine connected-5-substitured indole-monoclonal antibody CD33 conjugate and CD34 conjugate and preparation methods and application thereof
11/27/2013CN103408664A A-human CXCL1 monoclonal antibody or fragment thereof
11/27/2013CN103408663A Anti-human CXCL1 monoclonal antibody or fragment thereof
11/27/2013CN103408662A Preparation method of mice antiserum resisting toad skin transgelin-2 recombinant protein
11/27/2013CN103408661A Method of providing disease-specific binding molecules and targets
11/27/2013CN103408660A Monoclonal antibody of antiplague bacillus F1 antigen and application of monoclonal antibody
11/27/2013CN103408656A Morphine/heroin vaccine formed by covalently binding hapten and carrier, and application thereof
11/27/2013CN102731617B Hantavirus glucoprotein specific T cell epitope peptide and application thereof
11/27/2013CN102399266B Immunogenic peptide of humvoltage-gated potassium channel 1.5 (hKv1.5) and purpose thereof
11/27/2013CN102307900B Antibody modulating differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof
11/27/2013CN102112485B Synthesis of GLATIRAMER ACETATE
11/27/2013CN101443360B Binding member for GM-CSF receptor
11/26/2013US8592564 Immunoassays for lamotrigine
11/26/2013US8592563 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (VEGF)
11/26/2013US8592562 Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
11/26/2013US8592561 Antibodies for detecting or monitoring a malignant plasma cell disease
11/26/2013US8592560 Antibodies to apical intestinal receptors and methods of treating metabolic disease
11/26/2013US8592559 Antibody having activity of inhibiting hepatitis C virus (HCV) infection and use thereof
11/26/2013US8592555 Immunoglobulin-binding proteins with improved specificity
11/26/2013US8592379 Metastin derivative and use thereof
11/26/2013US8592152 Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy
11/26/2013US8591909 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
11/26/2013US8591907 Hypoallergenic variants of the major allergen from Betula verrucosa pollen
11/26/2013US8591904 Asymmetrically branched polymer conjugates and microarray assays
11/26/2013US8591902 Antibody binding to lysophosphatidylglucoside, and composition comprising the same
11/26/2013US8591901 Antibodies to TGF-β
11/26/2013US8591900 Anti-CD40 antibodies
11/26/2013US8591899 Diagnosis of Bacillus anthracis infection based on detection of bacterial secreted biomarkers
11/26/2013US8591898 Treatment of interstitial cystitis
11/26/2013US8591897 Anti-ERBB2 antibody adjuvant therapy
11/26/2013US8591896 Chemokine receptor binding polypeptides
11/26/2013US8591894 Humanized antibodies that sequester amyloid beta peptide
11/26/2013US8591891 Monoclonal antibodies against ANGPTL4
11/26/2013US8591887 EPHA2 as a therapeutic target for cancer
11/26/2013US8591885 Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
11/26/2013US8591863 Compositions against cancer antigen LIV-1 and uses thereof
11/26/2013CA2623652C Antibody-drug conjugates and methods of use
11/26/2013CA2618374C Trimeric collagen scaffold antibodies
11/26/2013CA2615918C Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
11/26/2013CA2541438C The modulation of hyaluronan synthesis and degradation in the treatment of disease
11/26/2013CA2511538C Immunostimulatory combinations
11/26/2013CA2482744C Hiv envelope-cd4 complexes and hybrids
11/26/2013CA2469472C Endothelial stem cells, populations, methods of isolation and use thereof
11/26/2013CA2450828C Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin
11/26/2013CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy
11/26/2013CA2279231C Activity dependent neurotrophic factor iii (adnf iii)
11/25/2013CA2815869A1 Method of determining the genotype relating to hereditary nasal parakeratosis (hnpk) and nucleic acids usable in said method
11/21/2013WO2013173761A2 St2 antigen binding proteins
11/21/2013WO2013173582A1 Hepatitis c virus neutralizing antibody
11/21/2013WO2013173496A2 Cd33 antibodies and use of same to treat cancer
11/21/2013WO2013173463A1 Erg/tff3/hmwck triple immunostain for detection of prostate cancer
11/21/2013WO2013173255A2 Antigen binding proteins that bind egfr
11/21/2013WO2013173223A1 Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
11/21/2013WO2013172379A1 Novel antibody and application thereof
11/21/2013WO2013172347A1 Method for detecting iga aggregate, and method for testing iga nephropathy
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 1494